158 related articles for article (PubMed ID: 6311149)
1. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
[TBL] [Abstract][Full Text] [Related]
2. Anti-EBV serologic tests for nasopharyngeal carcinoma.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W
Laryngoscope; 1980 Dec; 90(12):1981-90. PubMed ID: 6256597
[TBL] [Abstract][Full Text] [Related]
3. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
[TBL] [Abstract][Full Text] [Related]
4. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma.
Pearson GR; Weiland LH; Neel HB; Taylor W; Earle J; Mulroney SE; Goepfert H; Lanier A; Talvot ML; Pilch B; Goodman M; Huang A; Levine PH; Hyams V; Moran E; Henle G; Henle W
Cancer; 1983 Jan; 51(2):260-8. PubMed ID: 6295597
[TBL] [Abstract][Full Text] [Related]
5. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
Cevenini R; Donati M; Caliceti U; Moroni A; Tamba I; Rumpianesi F
J Infect; 1986 Mar; 12(2):127-31. PubMed ID: 3009628
[TBL] [Abstract][Full Text] [Related]
7. Immunologic detection of occult primary cancer of the head and neck.
Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH
Otolaryngol Head Neck Surg; 1981; 89(2):230-4. PubMed ID: 6264367
[TBL] [Abstract][Full Text] [Related]
8. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
[TBL] [Abstract][Full Text] [Related]
10. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
Sam CK; Prasad U; Pathmanathan R
Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
Ringborg U; Henle W; Henle G; Ingimarsson S; Klein G; Silfversward C; Strander H
Cancer; 1983 Oct; 52(7):1237-43. PubMed ID: 6309355
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
Littler E; Baylis SA; Zeng Y; Conway MJ; Mackett M; Arrand JR
Lancet; 1991 Mar; 337(8743):685-9. PubMed ID: 1672175
[TBL] [Abstract][Full Text] [Related]
13. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
Cheng YC; Chen JY; Glaser R; Henle W
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
15. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
[TBL] [Abstract][Full Text] [Related]
16. Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma.
Pirodda E; Caliceti U; Testoni S
J Exp Pathol; 1987; 3(4):479-83. PubMed ID: 2842481
[TBL] [Abstract][Full Text] [Related]
17. Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.
Desgranges C; de-The G
IARC Sci Publ (1971); 1978; (20):459-69. PubMed ID: 215528
[No Abstract] [Full Text] [Related]
18. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
Neel HB; Pearson GR; Taylor WF
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):477-82. PubMed ID: 6093669
[TBL] [Abstract][Full Text] [Related]
19. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
